Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2015

View Archived Issues

HIV Vaccine Trials Network launches phase I/II trial of prime-boost vaccine

IDRI receives BARDA funding to establish adjuvant hub

E Keppra approved in Japan as monotherapy for partial-onset seizures

Queen Mary University of London and Takeda to develop new gastroenterology therapies

Cerecor acquires kappa opioid receptor antagonist from Eli Lilly

Anti-IL-23 antibody shows clinical effect in Crohn's disease patients

Vichem Chemie Research discloses new FLT3 inhibitors

Anti-MZGP2 antibodies associated with Crohn's disease phenotypes

Actelion Pharmaceuticals patents new lipoxin receptor agonists

Roche patent reports new fusion proteins for Alzheimer's type dementia

New SHIP-2 inhibitors for diabetes designed by University of Toyama

Merck KGaA discloses multiple kinase inhibitors

Novo Nordisk reports positive results from phase II trial of oral semaglutide in type 2 diabetes

Valeant to acquire Salix Pharmaceuticals

Investigators prepare new anti-GARP MAbs

Allergan patents S1P1 receptor ligands

Sosei acquires Heptares Therapeutics

FDA grants orphan drug status to polidocanol for venous malformations

FDA grants priority review to Rapamune sNDA for lymphangioleiomyomatosis

AB-Biotics collaborates with Derbycare to launch AB-Kolicare in China

Shire completes acquisition of NPS Pharmaceuticals

First stem cell-based medicinal product approved in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...